Soleno Therapeutics (SLNO) Cash from Investing Activities Growth (1y) (2015 - 2026)
Soleno Therapeutics (SLNO) Cash from Investing Activities Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Soleno Therapeutics |
2.76 Bn |
2.51 Bn |
93.41 Mn |
65.60% |
| Date | Value |
|---|
| Mar 31, 2026 |
65.60% |
| Dec 31, 2025 |
-2,045.68% |
| Sep 30, 2025 |
-2,363.44% |
| Jun 30, 2025 |
93.45% |
| Mar 31, 2025 |
119.90% |
| Dec 31, 2022 |
53.85% |
| Dec 31, 2021 |
-225.00% |
| Dec 31, 2020 |
-103.88% |
| Dec 31, 2019 |
159.20% |
| Sep 30, 2019 |
8,920.00% |
| Dec 31, 2018 |
-1,260.00% |
| Sep 30, 2018 |
-103.50% |
| Dec 31, 2017 |
189.93% |
| Sep 30, 2017 |
741.18% |
| Mar 31, 2017 |
78.95% |
| Dec 31, 2016 |
47.51% |
| Sep 30, 2016 |
101.35% |
| Jun 30, 2016 |
33.33% |
| Mar 31, 2016 |
-1,800.00% |
| Jun 30, 2015 |
-900.00% |
